UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030464
Receipt number R000034787
Scientific Title Ispilateral shoulder pain after video-assisted thoracoscopy: a prospective, randomized, double-blind evaluation of the efficacy of infiltrationg the phrenic nerve at the vena azygos level.
Date of disclosure of the study information 2018/01/01
Last modified on 2021/01/08 10:48:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Ispilateral shoulder pain after video-assisted thoracoscopy: a prospective, randomized, double-blind evaluation of the efficacy of infiltrationg the phrenic nerve at the vena azygos level.

Acronym

Evaluation of the safety of infiltrationg the phrenic nerve at the vena azygos level.

Scientific Title

Ispilateral shoulder pain after video-assisted thoracoscopy: a prospective, randomized, double-blind evaluation of the efficacy of infiltrationg the phrenic nerve at the vena azygos level.

Scientific Title:Acronym

Evaluation of the safety of infiltrationg the phrenic nerve at the vena azygos level.

Region

Japan


Condition

Condition

Patients who are scheduled for elective lobectomy or pneumonectomy for non-small cell lung cancer, aged > 18 years

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To reduce the incidence of ipsilateral shoulder pain after video-assisted thoracoscopy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Postoperative pain was assessed using an 11-point numeric rating scale(NRS)

Key secondary outcomes

The excursion value of the shoulder
PONV


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Phrenic nerve block at the vena azygos level

Interventions/Control_2

Infiltrating the phrenic nerve with 0.375% ropivacaine before chest closure

Interventions/Control_3

Infiltrating the phrenic nerve, only once.

Interventions/Control_4

A post-operatively for 2 days observes total of 4 days from the way previous day.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients are scheduled for elective lobectomy or pneumonectomy for non-small cell lung cancer, aged > 18 years

Key exclusion criteria

Patients with contrateral palsy, allergy to ropivacaine, pre-operative history of ipsilateral shoulder pain

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kaori
Middle name
Last name Kuroiwa Kimura

Organization

Nagano Red Cross Hospital

Division name

Departments of Anesthesia

Zip code

380-8582

Address

5-22-1, Wakasato, Nagano, Japan

TEL

026-226-4131

Email

anesthesi0hanz13@yahoo.co.jp


Public contact

Name of contact person

1st name Kaori
Middle name
Last name Kuroiwa Kimura

Organization

Nagano Red Cross Hospital

Division name

Departments of Anesthesia

Zip code

380-8582

Address

5-22-1, Wakasato, Nagano, Japan

TEL

026-226-4131

Homepage URL


Email

anesthesi0hanz13@yahoo.co.jp


Sponsor or person

Institute

Nagano Red Cross Hospital
Departments of Anesthesia

Institute

Department

Personal name



Funding Source

Organization

Nagano Red Cross Hospital
Departments of Anesthesia

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagano Red Cross Hospital

Address

5-22-1, Wakasato, Nagano, Japan

Tel

0262264131

Email

anesthesi0hanz13@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

長野赤十字病院(長野県)


Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 01 Day


Related information

URL releasing protocol

https://journals.lww.com/anesthesia-analgesia/Fulltext/9900/Phrenic_Nerve_Block_at_the_Azygos_Vein_L

Publication of results

Published


Result

URL related to results and publications

Anesth Analg . 2020 Dec 16. doi: 10.1213/ANE.0000000000005305. Online ahead of print.

Number of participants that the trial has enrolled

85

Results

Eighty-five patients were included, and their data were analyzed. These patients were randomly assigned to either phrenic nerve block group (n = 42) or control group (n = 43). There were no clinically relevant differences in demographic and surgical profiles between the groups. There was no significant difference in the incidence of ipsilateral shoulder pain (the control group 20/43 [46.5%] versus the PNB group 14/42 [33.3%]; P = .215).

Results date posted

2021 Year 01 Month 08 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2020 Year 12 Month 16 Day

Baseline Characteristics

Inclusion criteria were as follows: patients scheduled for VATS, age >18 years, American Society of Anesthesiologists physical status level <3, and planned use of epidural anesthesia. Exclusion criteria were as follows: patients with contralateral paralysis of the phrenic nerve, allergy to ropivacaine, preoperative history of ISP, chronic pain, contraindications to epidural anesthesia, and/or dementia.

VATS:video-assisted thoracoscopic surgery
ISP:Ipsilateral shoulder pain

Participant flow

The principal investigator and coinvestigators screened patients for eligibility to participate in the study. The investigators explained the rationale of the study to patients who were eligible for study participation. Written informed consent was obtained from all enrolled patients.

Adverse events

In the control group, one patient experienced postoperative pneumonia.

Outcome measures

Postoperative ipsilateral shoulder pain was assessed using a numerical rating scale at rest at 2,4,8,16, and 24 hours. The incidence of ISP was defined as the proportion of patients who reported an NRS score of>=1 at least once within 24 hours after surgery.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 12 Month 10 Day

Date of IRB

2017 Year 12 Month 10 Day

Anticipated trial start date

2018 Year 01 Month 01 Day

Last follow-up date

2019 Year 01 Month 01 Day

Date of closure to data entry

2020 Year 12 Month 31 Day

Date trial data considered complete

2020 Year 12 Month 31 Day

Date analysis concluded

2020 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 12 Month 19 Day

Last modified on

2021 Year 01 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034787


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name